Track Strata Critical Medical, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Strata Critical Medical, Inc. SRTA · Stock Open Strata Critical Medical, Inc. in new tab

5.51 USD
EPS
-0.24
P/B
1.78
ROE
-7.55
Beta
2.56
Target Price
9.63 USD
Strata Critical Medical, Inc. logo

Strata Critical Medical, Inc.

🧾 Earnings Recap – Q3 2026

Shares rose 3.7% after earnings, as Strata reported Q3 results ahead of its guidance and record free cash flow. Clinical services growth and earlier-than-planned logistics margin progress supported management’s outlook for 2027.

  • Clinical services revenue grew more than 20% sequentially from Q2 2026, which management attributed partly to customers using Strata’s integrated transplant offering for more cases.
  • Logistics revenue was near the high end of guidance despite a larger-than-expected seasonal industry decline and shorter industry trip distances.
  • Strata said it reached its 2027 logistics gross margin target ahead of plan and reduced adjusted SG&A quarter over quarter.
  • Free cash flow reached a record $8.6 million; the company ended the quarter with roughly $42 million in cash and short-term investments, before an anticipated $27 million in passenger-sale consideration early next year.
  • Management said it expects high-teens organic adjusted EBITDA growth and 30%+ total adjusted EBITDA growth in 2027, including acquisitions; it also announced a $20 million share repurchase authorization.
📅
Loading chart...
Key Metrics
Earnings dateMarch 2, 2027
EPS-0.24
Book Value3.09
Price to Book1.78
Debt/Equity1.31
% Insiders14.352%
Growth
Revenue Growth0.50%
Estimates
Target Mean Price9.63

DCF valuation

Model fair value for Strata Critical Medical, Inc. (SRTA)
Result
Sign in to run the valuation for SRTA.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
4 analysts · consensus Strong buy · mean target 9.63 USD (low 8.00, high 13.00) · as of 15 Nov 2026
Low 8.00
Mean 9.63
High 13.00
Price 5.51
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Strata Critical Medical, Inc. Logo Strata Critical Medical, Inc. Analysis (SRTA)

Is Strata Critical Medical, Inc. a good investment? Strata Critical Medical, Inc. (SRTA) is currently trading at 5.51 USD. Market analysts have a consensus price target of 9.63 USD. This suggests a potential upside from current levels.

Earnings Schedule: Strata Critical Medical, Inc. is expected to release its next earnings report on March 2, 2027.

Investor FAQ

Does Strata Critical Medical, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Strata Critical Medical, Inc.?

Strata Critical Medical, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be March 2, 2027. The company currently has a trailing EPS of -0.24.

Company Profile

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.

Exchange Ticker
SRTA
NMS (United States) BLDE
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion